DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Geoerger B, Kang HJ, Yalon-Oren M. et al.
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial.
Lancet Oncol 2020;
21 (01) 121-133
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.